Form 4: Precigen CEO Helen Sabzevari Acquires 1,079,137 Restricted Stock Units

Precigen's President and CEO, Helen Sabzevari, reports the acquisition of 1,079,137 Restricted Stock Units (RSUs) that will vest on May 16, 2025.

Summary

• Helen Sabzevari, President and CEO of Precigen, Inc., filed a Form 4 on April 18, 2025.
• The report details the acquisition of 1,079,137 Restricted Stock Units (RSUs) on April 17, 2025.
• Each RSU represents a contingent right to receive one share of Precigen common stock.
• The RSUs will vest in full on May 16, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to executive compensation. The acquisition of RSUs can be seen as a positive sign of confidence, but it's also part of a compensation package.

Positives

• The acquisition of RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the RSUs on May 16, 2025, will result in the issuance of 1,079,137 shares of Precigen common stock to Helen Sabzevari.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the CEO's increased stake in the company.

Key Dates

Keywords

Form 4, Precigen, RSU, Helen Sabzevari, Beneficial Ownership, Restricted Stock Units, PGEN, CEO